TSE:MFC

Manulife Financial (MFC.TO)

61.37
+0.68 (1.12%)
as of Jul 24, 2026, 2:04:01 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 24, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered a range of responses from experts, showcasing a diverse outlook on its performance and market position. Many analysts note the company's solid fundamentals, including a strong dividend yield and healthy growth prospects, particularly in Asia and wealth management. However, there are concerns regarding its current valuation, as some believe it is slightly overbought and may be trading at high multiples compared to its earnings growth. While some experts recommend caution and suggest waiting for a market pullback before investing, others see the stock as an attractive long-term holding, especially given the ongoing positive momentum in its core business. Overall, despite fluctuations and some short-term challenges, MFC remains a reliable name in the insurance sector with potential for steady growth.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
GWO
BUY

Doesn’t see many of the Canadian insurers increasing dividends until they get more clarity on some of the regulatory rules with regard to capital. Cut their dividend in 2008 so probably won’t raise it again until they are very sure they are going to be able to maintain it. He is getting more positive on the Canadian insurance space; however the market has run these companies up in expectation of higher rates. It will have to be their core business that propels the next move in the stock. He would be cautious but thinks you should own some insurance in your portfolio. Prefers Sun Life (SLF-T), which has a better dividend yield and a little better stability.

BUY ON WEAKNESS

Closed at $21.59 and he has a model price of $24.36, a positive 13%. He thinks it runs to $23.66. If it comes back to the $19.40 level, he would certainly Buy.

BUY ON WEAKNESS

Sell or hold for more upside? When you see a chart like this one has, there is always a temptation to become a trader. There is probably more upside in this stock. Has been crushed because of lower interest rates. His view is there will be higher interest rates and this is very well-positioned, especially in Asia.

COMMENT

Manulife (MFC-T) or Sun Life (SLF-T)? Low interest-rate environment that we had been in for the last 3-4 years has been terrible for insurance companies. We are now in an environment where everybody expects bond yields to go up, which can only be positive for life companies going forward and it is expected to see better earnings on their portfolios. Feels this one probably has more leverage as it has more international exposure and a little bit more scale.

BUY ON WEAKNESS

On her watch list. Will benefit from rising interest rates. Likes their positioning in China and the Far East. Good growth avenue for them longer-term. Outperformed the banks last year. She would like to get it a couple of dollars cheaper.

PARTIAL BUY

Benefits from higher rates. 11.5 times earnings. He likes it. Would like to buy it under $20. He buys half now for new clients and hopes for a market pull back.

BUY

More growth in Manufacturers Life (MFC-T) or Sun Life (SLF-T)? These are both global businesses with large exposure to different parts of Asia. Both are international companies and he likes them both. Still sees upside as well as dividend increases in both companies over the next 2-3 years.

RISKY

Positive on the sector. This one is still a little more speculative than other names. As interest rates go up and stock markets continue to act well, it will be positive for MFC. See today’s Top Picks for his preferences.

BUY

If you are going to own one, prefers MFC-T.

HOLD

Very strong balance sheet. If you own, you may want to diversify a bit, keeping half of this and consider going into a U.S. Bank. Thinks the US currency is going to rise and feels that the US is going to grow a little faster than Canada. His top US bank holding is J.P. Morgan (JPM-N).

PAST TOP PICK

(A Top Pick Jan 30/13. Up 15.3%.)

BUY ON WEAKNESS

They have a benefit from higher rates but they have 35% growth in Asia, so you are going to see earnings growth. Buy on weakness at $19. Will raise dividend at the end of 2014.

COMMENT

Inter Pipeline (IPL-T) or Manulife (MFC-T) for a long-term hold? Feels this one is expensive as well. Operating earnings are getting better. This benefits from markets and interest rates, both going up.

PAST TOP PICK

(A Top Pick Dec 21/12. Up 50.16%.) Still sees value in this. Right now, the lifecos in particular, are in a cycle where, going forward, there is going to be more operating efficiencies. They are very cost conscious now. Also, expects there will be some operating leverages as the volume of business continues to expand. If interest rates start to rise, that is good for lifecos.

TOP PICK

Trading at low multiple. MCCSR is very robust right now. Will be a $25-$26 stock with the global economy doing so well right now.

Showing 1,066 to 1,080 of 2,283 entries